Skip to main content
. Author manuscript; available in PMC: 2019 Oct 22.
Published in final edited form as: Breast Cancer Res Treat. 2016 May 4;157(2):351–361. doi: 10.1007/s10549-016-3814-z

Table 3.

Hazard ratios (HRs) and 95 % confidence intervals (CIs) from final multivariable models of clinical and histopathological characteristics and molecular markers independently associated with subsequent tumor events

Variable Local invasive cancer HR (95 % CI) Regional/metastatic invasive HR (95 % CI)
Age at diagnosis (years) 1.0 (0.98–1.03) 1.01 (1.0–1.1)
Detection by palpation (vs. mammography) 2.1 (1.1–4.0) 2.4 (0.9–6.6)
Menopausal Status and p16
 Post- and negative Reference
 Post- and positive 1.7 (0.9–3.0)
 Pre- and negative 1.2 (0.2–9.6)
 Pre- and positive 5.8 (1.9–17.6)
p16/COX-2/ER/ERBB2
 Pos/Pos/Neg/Pos 5.2 (1.4–19.5)
 All other groupings 1.0 (referent)

Univariately significant variables were included in a backward/forward model selection approach

Palpable mass found by the woman or by her physician upon physical examination